Vaxcyte, Inc.

Vaxcyte, Inc.

PCVX
Vaxcyte, Inc.US flagNASDAQ Global Select
58.39
USD
+2.31
- -
8.43BMarket Cap

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+10.6% CAGR
Not enough positive-earnings history for a fair-value band

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
No data available

Revenue isn’t reported for PCVX.

EPS (Diluted)
Per-share earnings · loss years read red
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
No data available

Gross Profit & Margin isn’t reported for PCVX.

Operating Income & Margin
Bars with margin trend line
Operating incomeOperating margin
Net Income & Margin
Loss years read red
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
+27.0% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
No data available

Dividends & Payout Ratio isn’t reported for PCVX.

roic.ai · Fundamentals charts. Figures are not investment advice.